Home/Pipeline/b.Bone Bone Graft Substitute

b.Bone Bone Graft Substitute

Bone voids/gaps in extremities and pelvis (trauma, surgery)

ApprovedActive

Key Facts

Indication
Bone voids/gaps in extremities and pelvis (trauma, surgery)
Phase
Approved
Status
Active
Company

About GreenBone Ortho

GreenBone Ortho is a private, commercial-stage medical device company pioneering a novel biomaterial for bone regeneration. Its core technology transforms the natural microstructure of rattan wood into an inorganic, biomimetic hydroxyapatite scaffold that mimics human cancellous bone. With its CE-marked product b.Bone already on the market and supported by clinical evidence, the company is targeting a significant global opportunity in the bone graft substitute market. Key investors include 3B Future Health Fund, Innogest SGR, and CDP Venture Capital, providing financial backing for its commercial expansion and R&D.

View full company profile

Therapeutic Areas